Oncotelic Therapeutics, Inc. (OTLC)

Oncotelic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	14	15	18	63	19
Market Cap Growth	-6.64%	-6.64%	-13.25%	-71.94%	225.64%	34.48%
Enterprise Value	33	26	27	27	70	21
Last Close Price	0.05	0.04	0.04	0.04	0.17	0.21
PE Ratio	-	-	-	3.45	-	-
PS Ratio	-	-	218.13	-	-	11.06
PB Ratio	2.81	1.91	1.32	0.92	7.69	1.54
P/TBV Ratio	3.85	2.61	2.49	2.40	-	-
EV/Sales Ratio	-	-	384.58	-	-	12.14
Debt / Equity Ratio	1.75	1.75	1.08	0.59	1.10	0.37
Asset Turnover	-	-	0.00	-	-	0.07
Quick Ratio	0.01	0.01	0.01	0.02	0.04	0.04
Current Ratio	0.01	0.01	0.02	0.02	0.04	0.06
Return on Equity (ROE)	-50.08%	-50.08%	-53.28%	34.20%	-101.92%	-67.88%
Return on Assets (ROA)	-0.83%	-0.83%	-1.07%	-11.74%	-24.13%	-20.02%
Return on Capital (ROIC)	-1.05%	-1.05%	-1.29%	-14.73%	-33.27%	-27.09%
Earnings Yield	-21.51%	-31.74%	-51.76%	28.95%	-14.97%	-49.34%
Buyback Yield / Dilution	-5.29%	-5.29%	16.01%	-50.89%	-244.02%	-46.94%

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.